Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Join the community
Most Read
1. IHH Healthcare to expand network in India 2. What lies ahead for the cell and gene therapy market? 3. Global wearable medical device market to grow $143.7b by 2034 4. SMART launches project researching wearable ultrasound system for elderly care 5. Nearly 60% of Hongkongers delay medical care, report findsResource Center
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.